Story perspectives
CNS Drug Market Soars: J&J's $14.6B Acquisition Sparks Revival
1/15/2025
41 4
1 of 1
Story summary
- The global market for CNS disease drugs is booming, fueled by a surge in neurological disorders and innovative drug breakthroughs. Notably, Johnson & Johnson's impressive $14.6 billion acquisition of Intra-Cellular at the J.P. Morgan Healthcare Conference highlights a revitalized enthusiasm for biotech, marking a significant turnaround from earlier market slumps.
